Qualigen Therapeutics, Inc. , a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system.
Qualigen Therapeutics stock last closed at $3.48, down 0.85% from the previous day, and has decreased 76.41% in one year. It has overperformed other stocks in the Biotechnology industry by 0.01 percentage points. Qualigen Therapeutics stock is currently +22.11% from its 52-week low of $2.85, and -88.18% from its 52-week high of $29.44.
As of Apr 29, 2025, there are 736,431 shares of QLGN outstanding. The market capitalization of QLGN is $2.56M. In the last 24 hours, 4363 QLGN shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy QLGN shares.
Based on our analysis, eToro is the best stock brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you need to fill out some personal details so you can buy QLGN today.
Now that you've filled out your info on investing apps, your next step is to transfer the money for your investment:
Check out the tutorial below to see the process of depositing money into your new brokerage account.
Once you have identified the best place to buy Qualigen Therapeutics stock, it's very important to research their stock before you invest, so you truly comprehend the risk and opportunity.
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on QLGN's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge QLGN's true value.
You can do additional valuation research on QLGN's stock here.
You can dive deeper into what analysts are saying on the Qualigen Therapeutics stock forecast page.
Last year, QLGN revenue was $0.00. In the last five year, QLGN's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 45.47%.
You can research QLGN's earnings and revenue performance here.
In the past year, executives and large shareholders at QLGN have not bought or sold any shares.
Learn more about who owns QLGN stock here.
No, Qualigen Therapeutics doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two primary order types:
Hit the Open Trade button and your broker will place the order.
If you want more help investing in stocks on eToro, click the how to video below:
Now that you own some shares in QLGN, you'll want to keep up with your stock purchase.
Make a watchlist to track the latest developments regarding your QLGN stock.
To summarize, here are the 6 steps to buy stock in Qualigen Therapeutics:
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Qualigen Therapeutics, get started below.